Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2370 (LINC02370) is a member of the long intergenic non-coding RNA (lincRNA) family, which are autonomously transcribed RNA molecules longer than 200 nucleotides that do not overlap protein-coding genes. LincRNAs are a subclass of long non-coding RNAs (lncRNAs), responsible for a variety of regulatory functions in gene expression, particularly in epigenetic modulation and chromatin remodeling. While thousands of lincRNAs have been annotated, most—including LINC02370—have not been functionally characterized, and the majority are not established therapeutic targets. LincRNAs can serve as scaffolds for protein complexes, influence nuclear architecture, and regulate the transcription and stability of neighboring or distant genes. There are no drugs or direct disease roles currently attributed to LINC02370 in the published literature, and it is not classified as a druggable target, enzyme, transporter, or receptor.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2370 (LINC02370).